Ads
related to: antiemetic guidelines for chemotherapy medication for lung cancer- Treatment Information
Learn About This Lung Cancer
Option with Chemotherapy Today
- Dosing Schedules
Find Dosing Info & More
For This Treatment Option
- FAQs
Find FAQs for This
Treatment On The Official Site.
- Clinical Trial
Find Clinical Trial Info for This
Treatment Option with Chemo
- Treatment Information
Search results
Results From The WOW.Com Content Network
Chemotherapy for NSCLC usually includes combination of two drugs (chemotherapy doublet), with one of the agents is cisplatin or carboplatin. In 2002, Schiller at al. published in the New England Journal of Medicine, a study that compared four chemotherapy regimens for advanced NSCLC, cisplatin and paclitaxel, cisplatin and gemcitabine, cisplatin and docetaxel, and carboplatin and paclitaxel. [14]
The first-generation 5-HT 3 receptor antagonist (ondansetron, dolasetron, granisetron, and tropisetron) have been the most important drugs in antiemetic therapy for emetogenic chemotherapy. They are especially effective in treating acute emesis, occurring in the first 24 hours following chemotherapy. [38]
Non-small cell lung cancer and pancreatic cancer. Skin reactions, diarrhoea, GI bleeds, anaemia, dehydration, interstitial lung disease (uncommon), hepatic failure (rare), hepatorenal syndrome (rare), GI perforation (rare) and ulcerative keratitis (rare). Gefitinib: PO: EGFR inhibitor. EGFR-mutation positive non-small cell lung cancer.
A newer class of drugs known as the NK 1 antagonists are a recently developed class of very efficacious drugs for controlling CINV. These drugs are often used alongside 5HT 3 inhibitors and corticosteroids to form a very potent cocktail of antiemetics that verge on achieving a nearly complete patient response (that is, completely stopping CINV ...
An antiemetic is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, and chemotherapy directed against cancer. They may be used for severe cases of gastroenteritis, especially if the patient is dehydrated. [1] [2]
Average five-year survival rate for lung cancer patients is 25% because only 21% of lung cancers get diagnosed in early stage. How that could change Lung cancer screening guidelines updated, NY ...
Ads
related to: antiemetic guidelines for chemotherapy medication for lung cancer